Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy

Cornel Badorff(University of California, San Diego), Gil-Hwan Lee(University of California, San Diego), Barry J. Lamphear(University Medical Center), Maryann E. Martone(University of California, San Diego), Kevin P. Campbell(Howard Hughes Medical Institute), Robert E. Rhoads(University Medical Center), Kirk U. Knowlton(University of California, San Diego)
Nature Medicine
March 1, 1999
10.1038/6543
Cited by 568

Abstract

Related Papers

Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
James M. Ervasti, Kay Ohlendieck, Steven D. Kahl et al.|Nature|1990|1k
Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy
R. Mark Grady, Haibing Teng, Mia C. Nichol et al.|Cell|1997|630
Deletion of the Dystrophin Muscle-Promoter Region Associated with X-Linked Dilated Cardiomyopathy
Francesco Muntoni, Milena Cau, Antonello Ganau et al.|New England Journal of Medicine|1993|415
Cardiotrophin 1 (CT-1) Inhibition of Cardiac Myocyte Apoptosis via a Mitogen-activated Protein Kinase-dependent Pathway
Zelin Sheng, Kirk U. Knowlton, Ju Chen et al.|Journal of Biological Chemistry|1997|399
Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility.
M Koenig, Louis M. Kunkel|Journal of Biological Chemistry|1990|391